These findings provide evidence that elevated levels of PSMD11 and PSMD14 are closely related to AML drug resistance, indicating a potential role of hypoxia in contributing to poor AML prognosis through drug resistance. This evidence concerns the gene PSMD11 and acute myeloid leukemia.